Literature DB >> 8909521

Hepatic resections in normothermic ischemia.

G Nuzzo1, F Giuliante, I Giovannini, G D Tebala, G de Cosmo.   

Abstract

BACKGROUND: Reduction of operative blood transfusions is a primary goal in resective surgery of the liver. Temporary vascular inflow occlusion is an effective method to decrease hemorrhage during hepatic resection. This study was performed to assess the impact of normothermic ischemia on intraoperative bleeding and outcome after hepatic resection.
METHODS: Sixty-one hepatic resections were performed by using pedicle clamping alone or associated with total vascular exclusion of the liver. The mean duration of normothermic ischemia was 40 +/- 18 minutes (range, 7 to 98 minutes). Major resections were performed in 32 cases (52.5%).
RESULTS: Operative mortality was nil. Major complications occurred in 11.5% of cases. Twenty-five patients (41%) received intraoperative blood transfusions; mean +/- SD of transfused blood units was 2.4 +/- 1.3. Twelve major resections (37.5%) did not require any transfusion. Postoperative changes in liver function test results were moderate and transient.
CONCLUSIONS: The results of this study confirm the benefit of vascular occlusion techniques in reducing intraoperative bleeding and postoperative complications. The routine use of these techniques during hepatic resections, if applied properly and with the necessary precautions, is not associated with severe adverse effects on liver function.

Entities:  

Mesh:

Year:  1996        PMID: 8909521     DOI: 10.1016/s0039-6060(96)80094-8

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Liver resection using total vascular exclusion, scalpel division of the parenchyma, and a simple compression technique for hemostasis and biliary control.

Authors:  P D Hansen; A M Isla; N A Habib
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

2.  New technique for liver resection using heat coagulative necrosis.

Authors:  Jean-Christophe Weber; Giuseppe Navarra; Long R Jiao; Joanna P Nicholls; Steen Lindkaer Jensen; Nagy A Habib
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Use of a bipolar vessel-sealing device for parenchymal transection during liver surgery.

Authors:  Steven M Strasberg; Jeffrey A Drebin; David Linehan
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

4.  Hepatic surgery using the Ligasure vessel sealing system.

Authors:  Fabrizio Romano; Claudio Franciosi; Roberto Caprotti; Fabio Uggeri; Franco Uggeri
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

5.  Bloodless hepatectomy technique.

Authors:  G Navarra; D Spalding; D Zacharoulis; J P Nicholls; S Kirby; I Costa; N A Habib
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

6.  Ultrasonically activated device for parenchymal division during open hepatectomy.

Authors:  G Belli; P Limongelli; A Belli; C Fantini; A D'Agostino; L Cioffi; G Russo
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

7.  Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma.

Authors:  S Hao; S Chen; X Yang; C Wan
Journal:  Ann R Coll Surg Engl       Date:  2016-06-06       Impact factor: 1.891

8.  Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection.

Authors:  Oleg Heizmann; Georgios Meimarakis; Andreas Volk; Daniel Matz; Daniel Oertli; Rolf J Schauer
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

9.  Hepatic resection using a bipolar vessel sealing device: technical and histological analysis.

Authors:  Fabrizio Romano; Mattia Garancini; Roberto Caprotti; Giorgio Bovo; Matteo Conti; Elisa Perego; Franco Uggeri
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  Radiofrequency ablation-assisted liver resection: review of the literature and our experience.

Authors:  Peng Yao; David L Morris
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.